Mycophenolic acid (MPA), one of the most promising immunosuppressive drugs recently developed, is a potent inhibitor of IMP dehydrogenase, the first committed step of GMP synthesis. We found that all the drug effects on yeast cells were prevented by bypassing GMP synthesis, thus confirming the high specificity of MPA. Although the primary target of MPA is clearly identified we aimed to further understand how GTP depletion leads to growth arrest and developed a new approach based on proteome analysis combined with overexpression studies. Essential proteins down-expressed in the presence of MPA were identified by protein 2D gel analysis and subsequently overexpressed in yeast.
INTRODUCTION
Mycophenolic acid (MPA) in its morpholinoethyl ester prodrug form, mycophenolate mofetil (Cellcept, Roche), is one of the most promising immunosuppressive drugs recently developed. It is now widely used to prevent allograft rejection and may be an important alternative to cyclosporin A, which was recently demonstrated to induce tumor development (1) . MPA specifically inhibits inosine monophosphate dehydrogenase (IMPDH), the enzyme catalysing the first committed step in GMP biosynthesis ( Fig. 1 ) and consequently severely depletes the GTP cellular pool (down to 10% of normal levels) (2) . Although the primary target of MPA is clearly identified and human IMPDH has been crystallized in the presence of MPA (3), it is not yet clear how MPA treatment leads to immunosuppression. Two major questions are still unsolved: first, are all the MPA in vivo effects due 3 to decreased synthesis of GMP and second what are the consequences on cell physiology of GMP starvation caused by MPA treatment i.e. which proteins are the secondary targets of MPA. To address these questions, we have used a proteomic approach on yeast as a model eukaryotic system.
EXPERIMENTAL PROCEDURES
Yeast media SD, SD casa and SD S are as described (4, 5) . Uracil, leucine, lysine and guanine at final concentrations of 200 µg/ml, 600 µg/ml, 100 µg/ml and 0.13 mM, respectively, were optionally added.
Yeast strains The wild-type strain Saccharomyces cerevisiae Y350 (MATα; ura3-52; leu2-3,112; lys2 ∆201) was used for all experiments except for those presented in Fig. 6 , in which the following set of isogenic wild-type and disrupted strains purchased from Euroscarf was used: BY4742 (MATα; his3∆1; leu2∆0; lys2∆0; ura3∆0); cln1 (Y10785); cln2 (Y11036); cln3 (Y10366); mih1 (Y10612) and swe1 (Y11238).
Plasmids Plasmids pC166 (CDC37, URA3, 2µ), pSL2307 (PSA1, URA3, 2µ), pGS342 (SRP1, URA3, 2µ), pSP3545 (SUP35, SUP45, URA3, 2µ) and pAFS125 (TUB1-GFP, URA3, int) were kind gifts from M.Winey, G.S.Sprague, G.Schlenstedt, J.P.Rousset and A.Straight, respectively.
Growth plate tests Strains in exponential growth phase were resuspended in water to an OD600=1. Ten µl drops of this suspension and of four serial 1/10 dilutions of it were spotted on SD casa medium, supplemented or not with uracil and MPA, and incubated 4 days at 30 o C.
Microscopic analysis Yeast wild-type strain Y350 was grown overnight in SD casa U to an OD600=0.1. Then, the culture was divided in halves and MPA was added to one of them. Four hours latter (or 48 hours for calcofluor staining experiments) cells were imaged by microscopy. Conventional epifluorescence microscopy was performed on a Leica DMRXA microscope using a 100X immersion objective. DNA was visualised by fluorescence microscopy after staining with Hoechst 33342 dye (Molecular Probes, 1µg/ml). Cells were harvested, washed with water, and re-centrifugated. The pellet by guest on November 15, 2017 http://www.jbc.org/ Downloaded from 4 was then resuspended in 1µg/ml Hoechst and cells were incubated for 10 minutes in the dark before observation. Chitin was visualised by fluorescence microscopy after staining with Calcofluor white dye (Fluorescent Brightener 28, Sigma, 1 mg/ml) (6). For both DNA and chitin stainings, we used a standard UV filter cube (Leica A). For GFP studies, fluorescence was directly visualised in vivo using a standard FITC filter cube (Leica L4). Actin was visualised with rhodamin-phalloidin (7) using a standard TX filter cube (Leica TX). Images were acquired with a cooled CCD camera MicroMax (Princeton Instruments) controlled by the Metamorph 3.0 software (Universal Imaging Corporation).
FACS Yeast wild-type strain Y350 was grown overnight in SD S to an OD600=0.1. Aliquots of the culture were withdrawn and treated with 0, 0.03, 1, 30 or 100 µg/ml MPA, and with or without guanine. Four hours latter Flow Cytometry (FACS) analysis were performed. For results presented in Fig. 5b , the same experiment was done in SD casa with the Y350 (wild-type) strain overexpressing CDC37 or the URA3 control plasmid. Cells were harvested, fixed in 70% ethanol and stained with propidium iodide has described (8) . A DAKO Flow Cytometer was used for FACS analysis. Cell size is acquired with the forward angle light scatter (FSC) signal. DNA content is acquired with the red fluorescence from the propidium iodide dye, detected with a 633 nm filter directed to the FL3 channel.
Data from 50000 cells (acquired at a rate of approximately 200 events/second) were analyzed and prepared for presentation using the Flow Mate application.
Translation rate Y350 wild-type strain was grown overnight in SD S to OD600=0.5. Two ml aliquots of the culture were treated with 0, 0.03, 1, 30 or 100 µg/ml MPA for 60 minutes followed by in vivo protein labelling for 5 minutes by adding 100 µCi of [
35 S]-methionine (1000 Ci/mmol, ICN).
Protein sample preparation was carried out as described (9) and total radioactive incorporation was mesured. The intensity of each sample was compared to the control culture without MPA, corresponding to 100 % translation. Protein sample preparation and 2D gel electrophoresis were carried out as described (9) . Each 2D-pattern allows the visualization of 1000 spots, corresponding to approximately 1/6 of the yeast proteome. The radioactive gels were exposed to phosphor plates and images were scanned in a PhosphorImager (Molecular Dynamics). Quantification of spots and comparative analysis were performed with the ImageMaster 2D Elite software (Amersham Pharmacia Biotech). The intensity of each spot was normalized to 30 internal standards of different intensities (such as Act1p).
2D polyacrylamide gel electrophoresis and protein quantification
Normalization to the actin spot or to the global ratio of all matched spots on the gel gave similar results.
At least three independent 2D-patterns realized with different 35 S-labelled proteins extracts were analysed for each condition tested. Only proteins displaying at least two-fold intensity variations in response to MPA in all three experiments were considered.
Protein identification Proteins affected by MPA addition were all identified by matching 2D maps with a reference gel containing more than 400 previously identified proteins (10) .
Northern blots Yeast strain Y350 (wild-type) was grown overnight in SD casa U to an OD600=0.5, and the culture was then supplemented or not with 0.03 µg/ml MPA or with guanine.
Aliquots were withdrawn at the times indicated in Fig. 3 . For results presented in Fig. 5 , after reaching an OD600=0.5, the culture was supplemented or not with 30 µg/ml MPA and grown for one more hour.
RNA was isolated using the TRI Reagent RNA/DNA/PROTEIN Isolation Reagent (EUROMEDEX) (5) . RNA blots were prepared and probed with labelled PCR fragments (11) respectively. Addition of guanine, a GMP precursor which allows to overcome the lack of IMPDH activity (see Fig. 1 ), completely prevented the growth defect at all concentrations of MPA (Fig. 2a) .
Although MPA inhibited cell growth, resulting in large cells with abnormal DNA content ( actin patches (randomly distributed in the mother cell cortex) and exhibited either misoriented or no actin cables, compared to 2% (2/102) in the untreated cells (Fig. 2d) . Finally, MPA treated cells also displayed a defect in bud site selection, showing a random bud site selection instead of the normal axial budding haploid pattern (Fig. 2e ). All these effects were prevented by guanine addition (data not shown). Therefore, guanine nucleotides clearly play important roles in cell polarity.
MPA treatment affects a limited number of spots on the yeast protein map To gain insight
into the mechanism of action of MPA at the molecular level, a global approach based on a study of the yeast proteome was used. Since GTP plays an important role on translation, we first monitored the effect of MPA on this process. In vivo translation rates at 0.03, 1, 30 and 100 µg/ml of MPA were 104, 78, 49 and 0 % of the untreated MPA culture translation rate, respectively. We also performed a kinetic 7 study of MPA effect on the IMD2 gene expression, encoding yeast IMPDH (5, 12) . The effect of MPA and guanine on the IMD2 gene was maximal after 60 minutes treatment (Fig. 3) Three protein spots were more intense after growth in the presence of 1 µg/ml MPA (Table IA) .
The most strikingly induced protein was Imd3p, one of the three IMPDH homologs in yeast (Fig. 4a) .
The two other induced spots corresponded to proteins induced under various stress conditions, such as the heat shock protein Ssa4p (Fig. 4c) . Up regulation of the other two IMPDH homologs, Imd2p and Imd4p, could not have been observed because they are too basic and migrate outside of the 2D gels.
A total of 27 identified proteins were found less abundant after MPA treatment (Table IB) .
Among them are several enzymes of the IMP biosynthesis pathway, encoded by the ADE genes (Fig. 4a, 4b ). We interpret this result as follows: MPA treatment decreases GMP synthesis from IMP and consequently reroutes non metabolized IMP to AMP synthesis (see Fig. 1 ) which in turn results in transcriptional down regulation of the ADE genes (13) . The other spots corresponded mainly to carbon and amino acids metabolism enzymes (Table IB) .
All the observed MPA effects were completely prevented by concomitant guanine addition, except for Imd3p and some Ade proteins for which prevention was partial and probably reflects a competition between MPA and guanine during the labelling time-lapse.
Cdc37p and Sup45p limitation are partially responsible for MPA toxicity Among the 27 down regulated proteins, only six are encoded by essential genes, namely Psa1p, Cct5p, Cct8p, Cdc37p, Srp1p and Sup45p ( Fig. 4c and 4d) . Interestingly, Psa1p, is an essential enzyme responsible for GDPmannose synthesis which utilizes GTP as a substrate (14) . Cct5p and Cct8p are components of the multiprotein chaperonin-containing T-complex (15 Sup45p (eRF1) together with the GTPase Sup35p (eRF3) forms the translational release factor complex (16-18). In the presence of MPA, the GTPase activity of Sup35p could be affected and translation termination could be abnormal and affect cell growth. Our results therefore suggest that correct protein termination, an essential process for optimal growth, should be highly sensitive to GTP depletion. Nevertheless, overexpression of SUP45+SUP35 had no effect on the flow cytometry profiles (data not shown), clearly indicating that several independent processes are affected by MPA. assembly of active kinase complexes and thus act in coordination of events responsible for correct cell cycle progression and spindle duplication. Flow cytometry analysis revealed that overexpression of CDC37 significantly decreased both DNA content and cell size induced by MPA treatment (Fig. 5b) .
Moreover, the cellular defects of the cdc37 mutants correlate quite well with some morphological defects due to MPA treatment (18) (19) (20) . It is noteworthy that in mammals Cdc37 is highly expressed in proliferative tissues and functions as an oncogene in mice (21) We also examined whether down expression of Cdc37p in the presence of MPA was a consequence of inhibition of transcription. Result presented in Fig. 5c clearly established that MPA treatment did not affect the amount of CDC37 transcript while IMD2 expression was strongly affected, as previously described (5, 12) . Therefore, MPA affected Cdc37p expression at a post-transcriptional level and would not have been detected by a transcriptome analysis, thus illustrating the complementarity of transcription profiling and proteomic analysis. Such a transcriptome approach has been used by others to examine the effect of immunosuppressants cyclosporin A or FK506 on yeast (23) . In comparison to their study, our method not only uses global expression patterns, but also combines it with overexpression studies, further validating potential secondary targets.
The morphogenesis checkpoint: an important step for recovering from the effects of MPAWe
show for the first time that cell cycle regulation is affected by GTP depletion, since we observed that MPA induced increased DNA content and caused cytoskeleton defects , as well as random budding. Several G-proteins are involved in cellular polarization and bud site selection and could be the primary sensors of GTP depletion. Moreover, the morphological defects caused by MPA are similar to those observed in mutants such as cdc42, affected in bud-site assembly and cell polarity (24) , although overexpression of CDC42 did not result in increased MPA resistance (data not shown). Alternatively, tubulin polymerization proceeds through an active GTP-tubulin form and may therefore be directly affected by the MPA induced GTP depletion.
Because MPA treatment was found to cause actin patches depolarization (Fig. 2d) , the effect of mutations in the SWE1 and MIH1 genes, affecting the "morphogenesis checkpoint", was evaluated.
Under conditions of transient depolarization of the actin cytoskeleton, the protein kinase Swe1p
phosphorylates Cdc28p, inhibiting cell cycle progression through G2. This action of Swe1p is opposed by the protein phosphatase Mih1p. The mih1 mutant was found more resistant to MPA than the wildtype strain while on the opposite, the swe1 mutant showed increased sensitivity (Fig. 6) . Therefore, the mitotic G 2 /M delay controlled by the morphogenesis checkpoint appears as an important step to recover from the effects of MPA.
We establish that, in yeast, all MPA effects are consequences of IMPDH inhibition. In the case of decreased synthesis of IMP biosynthesis enzymes (ADE genes products) the MPA effect is most likely due to accumulation of IMP, the IMPDH substrate. In all other cases the MPA effect is clearly due to decreased synthesis of guanine nucleotides, since it can be bypassed by extracellular guanine.
Therefore, the critical effects of MPA must occur downstream of IMPDH (primary target) through the effect of guanine nucleotide deficiency on downstream targets (secondary targets). The proteome approach, combined to overexpression studies, allowed us to identify two essential proteins, Cdc37p
and Sup45p, the amount of which is limiting in MPA treated cells. Identification of such secondary targets, which are the cellular Achilles heels for a specific drug, is an important task to unravel the 11 therapeutic effects from the undesirable side effects. Proteome analysis combined with genetics is clearly a powerful tool to identify such important targets.
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